E. Lamers

发表

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.

P. Maxwell, C. Gourley, R. Kennedy, 2011, Gynecologic oncology.

PARP inhibition induces BAX/BAK‐independent synthetic lethality of BRCA1‐deficient non‐small cell lung cancer

P. Hamilton, K. O'Byrne, K. Kerr, 2011, The Journal of pathology.

PARP inhibition induces BAX/BAK‐independent synthetic lethality of BRCA1‐deficient non‐small cell lung cancer

P. Hamilton, K. O'Byrne, K. Kerr, 2011, The Journal of pathology.